Legalize59765 laws
59765 laws
- § 335b. Civil penalties
- § 335c. Authority to withdraw approval of abbreviated drug applications
- § 336. Report of minor violations
- § 337. Proceedings in name of United States; provision as to subpoenas
- § 337a. Extraterritorial jurisdiction
- § 341. Definitions and standards for food
- § 342. Adulterated food
- § 347a. Congressional declaration of policy regarding oleomargarine sales
- § 347b. Contravention of State laws
- § 1953. Antidrug program
- § 348. Food additives
- § 349. Bottled drinking water standards; publication in Federal Register
- § 350. Vitamins and minerals
- § 350a. Infant formulas
- § 350a–1. Protecting infants and improving formula supply
- § 350b. New dietary ingredients
- § 350c. Maintenance and inspection of records
- § 350d. Registration of food facilities
- § 353d. Process to update labeling for certain generic drugs
- § 354. Veterinary feed directive drugs
- § 355. New drugs
- § 355a. Pediatric studies of drugs
- § 355c. Research into pediatric uses for drugs and biological products
- § 355c–1. Report
- § 355d. Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers
- § 355f. Extension of exclusivity period for new qualified infectious disease products
- § 355g. Utilizing real world evidence
- § 360bbb–8d. Notification, nondistribution, and recall of controlled substances
- § 360b–1. Priority zoonotic animal drugs
- § 360c. Classification of devices intended for human use
- § 360cc. Protection for drugs for rare diseases or conditions
- § 387. Definitions
- § 360ccc. Conditional approval of new animal drugs for minor use and minor species and certain new animal drugs
- § 360ccc–1. Index of legally marketed unapproved new animal drugs for minor species
- § 360ccc–2. Designated new animal drugs for minor use or minor species
- § 360c–1. Reporting
- § 360eee–3. National standards for third-party logistics providers
- § 360eee–4. Uniform national policy
- § 360ee–1. FDA rare neurodegenerative disease grant program
- § 360e–1. Pediatric uses of devices
- § 360e–3. Breakthrough devices
- § 1435. Delegation of authority by Secretary
- § 360ff. Priority review to encourage treatments for rare pediatric diseases
- § 360fff. Definitions
- § 360fff–1. Submission of requests
- § 360fff–2. Eligibility determinations; data submission; filing
- § 360fff–3. GRASE determination
- § 360hh. Definitions
- § 360h–1. Program to improve the device recall system
- § 300x–67. Public health emergencies